Image-enhanced endoscopy for detection of second primary esophageal
squamous cell neoplasms in patients with hypopharyngeal squamous cell
carcinoma: prevalence, risk factors, and characteristics
Abstract
Objectives: Second primary esophageal squamous cell neoplasms (ESCNs)
are common in hypopharyngeal squamous cell carcinoma (HPSCC) patients
and are associated with poor prognoses. The effectiveness of
image-enhanced endoscopy (IEE) has not been well established. Design:
Retrospective study with patients proven HPSCC between April 2016 and
April 2018 receiving ESCNs screening via white-light imaging,
narrow-band imaging, and Lugol chromoendoscopy. Setting: Data were
collected from an electronic medical record at a single medical center
in Taiwan. Participants: The study population included a total number of
130 patients with HPSCC receiving ESCNs screening via white-light
imaging, narrow-band imaging, and Lugol chromoendoscopy Main Outcome
Measures: Clinical data, incidence, and stage of second primary
malignancy in HPSCC patients were obtained for statistical comparison.
Results: Of 99 eligible patients, second primary ESCNs prevalence was
31%. Of the 69 patients assigned to the follow-up group, 23 with
positive findings showed significantly increased previous histories of
second primary malignancies in the upper aerodigestive tract. Among
them, patients without symptoms at the time of IEE screening showed less
advanced T stages and higher percentages of receiving minimally invasive
therapy. Conclusions: Routine IEE screening is strongly recommended for
HPSCC patients and can improve the detection rate of ESCNs and
facilitate early-stage identification.